Jordan Chase Wengrod, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eukaryotic Initiation Factor-2 | 3 | 2015 | 181 | 0.930 |
Why?
|
Multiprotein Complexes | 2 | 2015 | 1119 | 0.620 |
Why?
|
Autophagy | 3 | 2015 | 1319 | 0.590 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2015 | 2058 | 0.510 |
Why?
|
Enzyme Activation | 1 | 2015 | 3592 | 0.320 |
Why?
|
Iron-Sulfur Proteins | 1 | 2024 | 83 | 0.220 |
Why?
|
Friedreich Ataxia | 1 | 2024 | 77 | 0.220 |
Why?
|
Phosphoprotein Phosphatases | 2 | 2015 | 329 | 0.210 |
Why?
|
Melanoma | 2 | 2015 | 5704 | 0.160 |
Why?
|
Databases, Protein | 1 | 2021 | 387 | 0.160 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 522 | 0.150 |
Why?
|
Amino Acids | 2 | 2015 | 1717 | 0.150 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 239 | 0.150 |
Why?
|
Phosphorylation | 4 | 2015 | 8311 | 0.130 |
Why?
|
Tunicamycin | 1 | 2015 | 108 | 0.120 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 979 | 0.120 |
Why?
|
Receptor Cross-Talk | 1 | 2015 | 116 | 0.120 |
Why?
|
HLA Antigens | 1 | 2019 | 1371 | 0.110 |
Why?
|
Gene Knock-In Techniques | 1 | 2015 | 421 | 0.110 |
Why?
|
Unfolded Protein Response | 1 | 2015 | 234 | 0.100 |
Why?
|
Activating Transcription Factor 4 | 1 | 2013 | 84 | 0.100 |
Why?
|
Immunoprecipitation | 1 | 2015 | 877 | 0.100 |
Why?
|
Mass Spectrometry | 2 | 2021 | 2189 | 0.100 |
Why?
|
RNA Helicases | 1 | 2013 | 144 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1367 | 0.100 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2667 | 0.100 |
Why?
|
Chloroquine | 1 | 2013 | 274 | 0.100 |
Why?
|
RNA-Binding Proteins | 2 | 2013 | 1897 | 0.090 |
Why?
|
Mitochondria | 2 | 2024 | 3624 | 0.090 |
Why?
|
Deoxycytidine Kinase | 1 | 2010 | 11 | 0.090 |
Why?
|
Proteome | 1 | 2021 | 1861 | 0.090 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2757 | 0.080 |
Why?
|
Stress, Physiological | 2 | 2013 | 1400 | 0.080 |
Why?
|
RNA, Messenger | 3 | 2013 | 12785 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2015 | 1301 | 0.070 |
Why?
|
Sirolimus | 1 | 2015 | 1533 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 1 | 2013 | 1075 | 0.070 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2647 | 0.070 |
Why?
|
Cell Death | 1 | 2013 | 1664 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2013 | 2060 | 0.070 |
Why?
|
HeLa Cells | 1 | 2013 | 3097 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2015 | 1974 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2011 | 988 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3344 | 0.060 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3428 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2007 | 1164 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3610 | 0.050 |
Why?
|
Trans-Activators | 1 | 2013 | 2858 | 0.050 |
Why?
|
Mutation | 3 | 2019 | 30025 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5421 | 0.050 |
Why?
|
Alternative Splicing | 1 | 2007 | 1091 | 0.050 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11070 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5663 | 0.050 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 16945 | 0.050 |
Why?
|
Methyltransferases | 1 | 2024 | 377 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2010 | 2646 | 0.040 |
Why?
|
Cryoelectron Microscopy | 1 | 2024 | 650 | 0.040 |
Why?
|
Mitochondrial Membranes | 1 | 2021 | 177 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2011 | 4748 | 0.040 |
Why?
|
MicroRNAs | 1 | 2013 | 3796 | 0.030 |
Why?
|
Protein Biosynthesis | 1 | 2024 | 2114 | 0.030 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 869 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 11653 | 0.030 |
Why?
|
Humans | 12 | 2024 | 760437 | 0.030 |
Why?
|
Mice | 4 | 2021 | 81402 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5815 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 11900 | 0.030 |
Why?
|
Transcription Factors | 1 | 2013 | 12121 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7208 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2326 | 0.030 |
Why?
|
Signal Transduction | 1 | 2015 | 23397 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2013 | 285 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2019 | 4808 | 0.020 |
Why?
|
Arabinonucleosides | 1 | 2010 | 34 | 0.020 |
Why?
|
Biotransformation | 1 | 2010 | 166 | 0.020 |
Why?
|
Adenine Nucleotides | 1 | 2010 | 111 | 0.020 |
Why?
|
Protein Subunits | 1 | 2013 | 942 | 0.020 |
Why?
|
Animals | 4 | 2021 | 168253 | 0.020 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2010 | 411 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2010 | 1141 | 0.020 |
Why?
|
Internet | 1 | 2021 | 3092 | 0.020 |
Why?
|
RNA Splicing | 1 | 2013 | 915 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6908 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2010 | 281 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2545 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1847 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 2010 | 1122 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8466 | 0.020 |
Why?
|
Software | 1 | 2021 | 4426 | 0.020 |
Why?
|
Boston | 1 | 2019 | 9326 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 1540 | 0.020 |
Why?
|
Lymphoproliferative Disorders | 1 | 2010 | 533 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2010 | 1792 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3249 | 0.020 |
Why?
|
RNA Stability | 1 | 2007 | 331 | 0.020 |
Why?
|
Introns | 1 | 2007 | 981 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2137 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2013 | 3710 | 0.010 |
Why?
|
Exons | 1 | 2007 | 2392 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6525 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 15867 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2013 | 11096 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23953 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 39947 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5662 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15598 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 58859 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2010 | 6475 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29551 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64591 | 0.010 |
Why?
|
Risk Factors | 1 | 2019 | 74055 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80430 | 0.010 |
Why?
|
Male | 2 | 2019 | 360035 | 0.000 |
Why?
|
Aged | 1 | 2019 | 168840 | 0.000 |
Why?
|
Middle Aged | 1 | 2019 | 220382 | 0.000 |
Why?
|
Neoplasms | 1 | 2013 | 22083 | 0.000 |
Why?
|
Female | 1 | 2019 | 391875 | 0.000 |
Why?
|